Melasma treatment in Korea should begin with confirmation of the pigmentation condition, not selection of a laser package. A clinician may recommend sun and visible-light protection and topical treatment, with procedures considered selectively; improvement can take months and pigmentation can return. A short Seoul visit is therefore best planned around assessment and a sustainable follow-up plan, rather than a promised cure. The American Academy of Dermatology (AAD) treatment guide explains why there is no single best treatment for everyone.
Confirm melasma before treating a dark patch
Melasma commonly appears as blotchy brown pigmentation on both sides of the face. Its appearance can overlap with post-inflammatory hyperpigmentation (PIH), freckles, lentigines and other pigment disorders. PIH follows inflammation or injury, while an acne scar involves a change in skin texture; these concerns can coexist but should not be treated as interchangeable. DermNet’s melasma overview describes the differential diagnosis.
Bring the timeline of your patches: when they appeared, whether acne or a procedure preceded them, and whether they changed with pregnancy, hormonal treatment or sun exposure. A dermatologist may use examination, a Wood’s lamp or a dermatoscope; occasionally another investigation is needed to exclude a different condition. AAD diagnosis guidance supports assessment before treatment.
Terms such as epidermal, dermal and mixed melasma describe pigment location, not reliable categories you can assign from a phone photo or patch color. For the separate texture-versus-color discussion, see our acne-scar consultation guide.
Make sunlight and visible-light protection practical
UV exposure and visible light can contribute to melasma. AAD recommends shade, a wide-brimmed hat and broad-spectrum, water-resistant sunscreen with SPF 30 or higher. Outdoors, reapply at least every two hours and follow product instructions after swimming or sweating. Tinted sunscreen containing iron oxide can also help protect against visible light, particularly for darker skin tones. AAD’s self-care guidance explains these measures.
Choose protection you can use consistently during sightseeing and after returning home. Ask the clinician to review your sunscreen rather than assuming any tint provides the same protection. Makeup is not a substitute for adequate sunscreen. Plan shaded breaks and avoid tanning; a procedure does not remove the need for daily protection.
Treat irritation as information, not proof of progress
Burning, stinging or persistent irritation is not evidence that a brightening product is working. Irritating skin care may darken marks, and AAD recommends gentle, fragrance-free products. AAD self-care advice makes tolerability part of melasma care.
Bring photographs or ingredient labels for cleansers, acids, scrubs, brightening serums and prescriptions. Explain what happened when you used each product, not just its brand. Avoid building an aggressive new routine from several online recommendations. Ask the treating clinician how your current products fit together and what to do if irritation develops; medication instructions should be individualized.
Use a consultation decision map, not a device menu
The useful question is not simply which treatment is strongest. It is what the assessment shows, what risks matter for your skin and what care you can sustain. AAD describes individualized treatment; DermNet cautions that procedures may worsen melasma or cause PIH. AAD treatment guidance; DermNet procedural cautions.
| Consultation finding or constraint | Question to ask | Decision to document |
|---|---|---|
| Diagnosis is uncertain or several pigment concerns coexist | Which areas are melasma, and what else needs assessment? | Diagnosis and any further evaluation before treatment |
| Products currently sting or irritate | How does irritation affect the proposed plan? | Clinician-approved skin-care instructions and review point |
| A topical is proposed | Why this option, and what safety or tolerance checks apply? | Intended goal, instructions and follow-up |
| A laser, light treatment or peel is proposed | Why add it now rather than continue nonprocedural care? | Expected benefit, worsening-pigment risk and alternatives |
| You leave Seoul soon | Who will reassess the skin and handle problems at home? | Named follow-up responsibility and records handover |
This table is a consultation aid, not a self-treatment algorithm. A reasonable outcome can be further assessment or a nonprocedural plan rather than treatment that day.
Understand the context for topical choices
Depending on the assessment, prescription options can include hydroquinone, tretinoin-containing combinations or a triple-combination cream. Other agents, such as azelaic acid, may be considered. These are examples from AAD’s treatment overview, not a shopping list or confirmation that SOONPLUS supplies them.
Ask why the proposed option suits your diagnosis, skin tone, previous response and health history. Request clear instructions from the prescriber, a review plan and guidance about irritation. Do not copy someone else’s combination or frequency. Pregnancy considerations and product tolerability can change the discussion.
Topicals and light protection are often foundational, but progress is individual and may take months. Agree on how response will be assessed rather than judging a treatment after a few travel days.
Put lasers, light treatments and peels in context
A laser or light procedure may sometimes be added to medication and protection. It is not a guaranteed standalone cure. DermNet discusses Q-switched, fractional and picosecond lasers and intense pulsed light, while warning about relapse, resistance and worsening pigmentation. Peels can also aggravate melasma or PIH. DermNet treatment discussion; AAD procedural context.
A device name or the word “toning” does not explain your risk. Ask who selects the treatment, why it is appropriate now, how prior reactions affect the decision, and what would prompt reassessment. No fixed repeat schedule suits everyone. This article does not confirm any particular device or melasma procedure at SOONPLUS.
Request written aftercare and a route to direct care for unexpected, persistent or worsening reactions. Severe blistering or swelling, infection signs or breathing difficulty require urgent medical evaluation; do not wait for an online booking reply.
Have Questions About Facial Pigmentation?
Request an individualized consultation with the SOONPLUS clinic team in Gangnam.
REQUEST CONSULTATIONDisclose pregnancy plans and discuss oral tranexamic acid carefully
Pregnancy, breastfeeding and hormonal history
Tell the clinician if you are pregnant, breastfeeding or planning pregnancy before discussing prescriptions or procedures. Tretinoin should not be used during pregnancy, according to Cleveland Clinic’s melasma guidance. Ask the treating clinician to approve any proposed medication for your circumstances.
Hormonal influences may be relevant to melasma, but that is not a reason to change contraception or other hormonal medication yourself. Bring the medication history and discuss it with the relevant prescriber. DermNet describes hormonal associations.
Oral tranexamic acid is a medical decision
Oral tranexamic acid (TXA) is sometimes considered for melasma, but it requires a health-history review. In particular, disclose any history of blood clots and your current medicines. AAD highlights clot-history screening. It should not be self-started from an online regimen; this guide provides no dosing instructions or assurance of suitability.
Plan for recurrence and measurable maintenance
Melasma can improve and later return. Recurrence does not automatically mean a more aggressive procedure is needed. Long-term protection remains important, and a clinician should reassess changed pigmentation before revising treatment. DermNet describes chronicity and recurrence.
Agree on a maintenance plan that distinguishes daily protection, any prescribed care and scheduled review. Ask what improvement would count as meaningful, when response should be reviewed and which changes need earlier contact. Do not assume a maintenance plan means indefinite use of every initial prescription.
Standardized photographs can support monitoring. Keep lighting, angle and distance similar, avoid filters and record dates; DermNet describes serial photography and clinical severity measures. Photos help comparison but do not replace examination or diagnose pigment depth.
Bring a useful one-page pigmentation record
A concise record makes the consultation more informative than a list of treatments you want. Include unknowns rather than guessing. Medication history matters because other disorders and medication-related pigmentation can resemble melasma. Cleveland Clinic supports diagnosis and medication review.
- Onset and pattern: approximate start date, affected areas and changes over time.
- Context: acne, irritation, sun exposure, pregnancy or hormonal-treatment history around onset.
- Products and medicines: names or packaging photos, prescription status, allergies and reactions.
- Procedures: dates, clinic records, device name if documented, and whether pigmentation improved or worsened.
- Health disclosures: pregnancy plans, breastfeeding, clot history and other relevant conditions.
- Practical limits: Seoul departure date, access to a clinician at home and budget for continuing care.
Add a simple treatment log: date, clinician-directed change, skin response and questions for review. Keep prior treatment records separate from advertisements. This helps avoid repeating an approach that caused problems without recognizing the history.
Separate a short Seoul visit from sustained follow-up
A short visit can support examination, diagnosis discussion and written planning. It cannot demonstrate durable control of a condition whose improvement may take months. AAD discusses variable treatment response. Do not compress procedures into a trip simply to finish a prepaid package.
Before travel, ask what records are useful and whether the intended appointment is assessment only. Before any treatment, clarify required reviews, expected aftercare and whether your departure leaves enough time for the treating clinician’s plan. There is no universal safe stay for every melasma intervention.
Before leaving, request your diagnosis, treatment details, written instructions and contact pathway. Confirm what remote follow-up, if any, is available and when in-person care at home is needed. Our Gangnam visit-planning article offers broader planning context, not a melasma recovery timetable.
Clarify clinician roles, quotes and SOONPLUS scope
Ask who will diagnose the pigmentation, prescribe medication, select any procedure and manage adverse reactions. A coordinator can explain booking and logistics, but clinical decisions should come from the responsible clinician. Request the clinician’s name, role and relevant experience rather than inferring expertise from a clinic label. See our clinic consultation questions guide for broader comparison questions.
Request an individualized written quote after assessment. Separate consultation, proposed treatment, prescribed products, follow-up and possible maintenance costs; ask what is included and what remains uncertain. No general price can establish the cost or number of treatments you will need.
The official SOONPLUS homepage describes general dermatology, skin-aesthetic and skin-type assessment scope. It does not establish dedicated melasma services, particular prescriptions, laser availability or specialist staffing. Explore SOONPLUS dermatology consultation information and skin-treatment consultation information, then ask about current melasma assessment, treatment or referral availability.
Once your record and questions are ready, request a SOONPLUS skin-assessment consultation. Include your travel dates and ask who can evaluate the pigmentation. An inquiry does not confirm diagnosis, treatment suitability or final cost.
